Cancer/Testis Antigen 1

Preferred Label : Cancer/Testis Antigen 1;

NCIt synonyms : L Antigen Family Member 2; CTAG1; ESO1; NY-ESO-1; CTAG1B; CT6.1; Autoimmunogenic Cancer/Testis Antigen NY-ESO-1; Cancer/Testis Antigen 6.1; LAGE-2; New York Esophageal Squamous Cell Carcinoma 1; CTAG; CTAG1A; Cancer-Testis Antigen-1;

NCIt definition : Cancer/testis antigen 1 (180 aa, 18 kDa) is encoded by both the human CTAG1A gene and the human CTAG1B gene. This protein may be involved in both testis development and spermatogenesis.;

Détails

Origin ID

C39286;

UMLS CUI

C0536940;

OMIM relation
- Acyl-coa synthetase long chain family, member 4 [OMIM gene]
- Cancer/testis antigen 1b [OMIM gene]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
UMLS correspondences (same concept)
- CTAG1B protein, human [MeSH concept]
- CTAG1B protein, human [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- Pediatric Oncology Target Cell Lineage Determinant Terminology [NCIt concept]
gene_encodes_gene_product
- CTAG1A Gene [NCIt concept]
- CTAG1B Gene [NCIt concept]
- Cancer Gene [NCIt concept]
- Immunoprotein Gene [NCIt concept]
gene_product_plays_role_in_biological_process
- Immune System Process [NCIt concept]
- Metastasis Induction [NCIt concept]
- Tumorigenesis [NCIt concept]
is_target
- ALVAC(2)-NY-ESO-1 (M)/TRICOM Vaccine [NCIt concept]
- Allogeneic Anti-NY-ESO-1-TCR-IL-15-transduced Cord Blood-derived Natural Killer Cells [NCIt concept]
- Anti-HLA-A2/NY-ESO-1 TCR-transduced Autologous T Lymphocytes [NCIt concept]
- Anti-NY-ESO-1 Immunotherapeutic GSK-2241658A [NCIt concept]
- Anti-NY-ESO1/LAGE-1A TCR/scFv Anti-CD3 IMCnyeso [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/CD8alpha-expressing T-cells GSK3901961 [NCIt concept]
- Autologous Anti-NY-ESO-1 TCR/dnTGF-BRII-expressing T-cells GSK3845097 [NCIt concept]
- Autologous Anti-NY-ESO-1 mTCR Retroviral Vector Transduced PBLs [NCIt concept]
- Autologous Enhanced NY-ESO-1 TCR Engineered T-cells GSK4427296 [NCIt concept]
- Autologous NY-ESO-1 TCR-targeted T Lymphocytes [NCIt concept]
- Autologous NY-ESO-1-Melanoma-Specific CD8+ T-lymphocytes [NCIt concept]
- Autologous NY-ESO-1-specific CD8-positive T Lymphocytes [NCIt concept]
- Autologous NY-ESO-1/LAGE-1a-specific HLA-A*02:01-restricted TCR-expressing T-lymphocytes MDG1015 [NCIt concept]
- Autologous Peripheral Blood Lymphocytes Cotransduced with Retroviral Vectors Encoding Inducible IL-12 and Anti-NY-ESO-1 TCR [NCIt concept]
- Baloramotide [NCIt concept]
- CHP-NY-ESO-1 Peptide Vaccine IMF-001 [NCIt concept]
- Donor-derived WT1/PRAME/NY-ESO-1/Survivin-specific T-lymphocytes [NCIt concept]
- ESO-1 (161-180) Peptide Vaccine [NCIt concept]
- ESO-1 Reactive Autologous Peripheral Blood Lymphocyte [NCIt concept]
- ESO-1 Reactive Autologous Tumor Infiltrating Lymphocyte [NCIt concept]
- ESO-1:157-165(165V) Peptide [NCIt concept]
- Genetically Engineered NY-ESO-1-specific T Lymphocytes [NCIt concept]
- Immunotherapeutic Combination Product CMB305 [NCIt concept]
- KLH/NY-ESO-1/MART-1 Peptide-pulsed Dendritic Cell Vaccine [NCIt concept]
- Letetresgene Autoleucel [NCIt concept]
- Long Peptide Vaccine 7 [NCIt concept]
- Montanide ISA-51 VG/KLH/NY-ESO-1/MART-1 Peptide Vaccine [NCIt concept]
- Multi-antigen-directed Autologous T-cells NEXI-002 [NCIt concept]
- NY-ESO-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1 Peptides/Threitolceramide-6-loaded Nanoparticles PORT-3 [NCIt concept]
- NY-ESO-1 Protein Vaccine Plus Montanide ISA-51 VG [NCIt concept]
- NY-ESO-1 Reactive TCR Retroviral Vector Transduced Autologous PBL [NCIt concept]
- NY-ESO-1(157-165) Peptide-pulsed Autologous Dendritic Cell Vaccine [NCIt concept]
- NY-ESO-1-expressing Artificial Adjuvant Vector Cells ASP0739 [NCIt concept]
- NY-ESO-1/GLA-SE Vaccine ID-G305 [NCIt concept]
- NY-ESO-1/LAGE-1 Peptide Vaccine [NCIt concept]
- NY-ESO-1/MAGE-A4/PRAME/Survivin/SSX2-specific Autologous Cytotoxic T Lymphocytes [NCIt concept]
- Rasdegafusp Alfa [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Poly ICLC Vaccine [NCIt concept]
- Tetravalent RNA-lipoplex Cancer Vaccine BNT111 [NCIt concept]
- Trastuzumab Imbotolimod [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients